Navigation Links
Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics
Date:5/29/2008

New Rochelle, NY, May 29, 2008Subjects with type 1 or type 2 diabetes who self-monitor their blood glucose levels more frequently and use the results to adjust treatment regimens can achieve improved glucose control, according to a collection of state-of-the-art reports that comprise a Special Supplement to the June 2008 issue (Volume 10, Supplement 1) of Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at http://www.liebertonline.com/dia

"Increased frequency of self-monitoring of blood glucose (SMBG) has been shown to significantly improve glucose control. SMBG not only complements A1C results, it guides the patient for self-management of diabetes at home on a day-to-day basis," writes Editor-in-Chief, Satish K. Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado at Denver and Health Sciences Center, in a supplement overview.

Spanning the clinical, practical, and economic implications of SMBG, the supplement includes papers probing the technology behind state-of-the-art glucose meters and self-monitoring techniques, SMBG in pregnancy, and SMBG in the Asia-Pacific Region.

Shoba Subramanian, MD, and Irl Hirsch, MD, of the University of Washington, Seattle, review the evidence supporting frequent SMBG, recent advances in glucose meters and SMBG data processing and how it can be applied for more effective type 1 diabetes management, as well as the potential barriers to use of frequent SMBG that limit its applicability, in an article entitled, "The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes."

Focusing on type 2 diabetes, Nalinee Poolsup, PhD, from Silpakorn University, Nakhon-Pathom, Thailand, and Naeti Suksomboon, PharmD, PhD and Warisara Jiamsathit, MScPharm, from Mahidol University, Bangkok, Thailand, conclude that SMBG can yield a significant decrease in HbA1C levels in patients with type 2 diabetes when the results of SMBG are used to adjust therapeutic regimens. They describe the benefits of SMBG in "Systematic Review of the Benefits of Self-Monitoring of Blood Glucose on Glycemic Control in Type 2 Diabetes Patients."

In a forward-looking report entitled, "The Future of Self-Monitored Blood Glucose: Mean Blood Glucose Versus Glycosylated Hemoglobin," Roger Mazze, PhD, from the University of Minnesota Medical School, Minneapolis, emphasizes the importance of SMBG in monitoring diurnal glucose patterns, rather than relying solely on HbA1C or mean glucose levels, which can be misleading indicators of therapeutic efficacy.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: